Back to All Events

Gastrointestinal Drugs Advisory Committee

The Committee will discuss a new drug application (NDA 210166) for prucalopride tablets for oral administration, submitted by Shire Development, LLC, proposed for the treatment of chronic idiopathic constipation in adults.